Avancia Venture is a specialist pre-seed and seed investor in payment technology and medical technology — two markets where regulation is deep, incumbents are slow, and technical founders win. We write first cheques and stay close for the decade that follows.
Payments and healthcare share a structure: enormous, regulated, intermediated by legacy systems, and only recently programmable. We invest where a technical wedge compounds into infrastructure.
Money movement is being unbundled into APIs. We back the rails, risk engines, and compliance layers that let the next generation of financial products exist — with a bias toward businesses that own a regulated capability rather than resell one.
Clinical care is moving from episodic to continuous. We fund devices, diagnostics, and software that generate defensible clinical evidence early and have a credible path through regulatory clearance and reimbursement.
We make a small number of investments each year so that every founder gets a partner's attention rather than a portfolio manager's. A clear yes or no within three weeks — never a maybe held open for months.
A single 45-minute call with a partner. No associate screens, no deck-forwarding chain, no gatekeeping.
Two weeks of technical, regulatory, and market work drawing on our operator and clinical network.
A committed answer inside three weeks, with terms we can explain in a paragraph and won't renegotiate.
Hiring, licensing, payer and processor introductions, and follow-on capital through every subsequent round.
A selection of the businesses building in our two focus areas.
Real-time account-to-account payment rails for mid-market marketplaces.
Point-of-care molecular testing with results in under twelve minutes.
Risk decisioning infrastructure for cross-border merchant onboarding.
Continuous cardiac monitoring patch with autonomous arrhythmia triage.
Stablecoin settlement and treasury tooling for emerging-market importers.
Home dialysis hardware designed around a two-hour setup, not two days.
Payout orchestration for platforms paying contractors in 40+ currencies.
Low-field portable MRI paired with reconstruction models for rural clinics.
Programmable issuing for regulated fleet and healthcare spend.
Portfolio details shown for illustration. Full list and case studies available to prospective LPs on request.
"The hardest problems in payments and in medicine look nothing alike from the outside. Underneath, both are won by the team that understands the regulation better than anyone else in the room."— Founding Partner, Avancia Venture
Our partners have built and scaled licensed payment businesses and taken regulated medical devices through clearance. We've been on the other side of the table.
Built and sold a cross-border acquiring business; spent a decade in scheme and regulatory work across three continents.
Interventional cardiologist turned operator. Led two Class II devices through FDA clearance and first reimbursement.
Works with founders on hiring, licensing strategy, and the first twenty enterprise conversations.
Leads technical diligence across both sectors and runs our clinical and processor advisory network.
Send us the shortest version of what you're building and why now. Every submission is read by a partner, and we reply either way — usually within five working days.